Atomoxetine hydrochloride

Product Name: Atomoxetine hydrochloride
CAS No.: 82248-59-7
Chemical Name: Atomoxetine hydrochloride
Synonyms: ATOMOXETINE;Strattera;ATOMOXETINE HCL;ATOMOXITINE;Atomoxetine HCI;LY 139603;LY 139603 HCl;Atazanavir HCl;Atomoxitine HCL;(R)-Atomoxetine HCl
CBNumber: CB5757860
Molecular Formula: C17H22ClNO
Formula Weight: 291.82
MOL File: 82248-59-7.mol

More

Less

Atomoxetine hydrochloride Property

Melting point:: 167-169°C
alpha: D25 -38.01°; 36525 -177.26° (c = 1 in methanol); D23 -41.37° (c = 1.02 in methanol); D25 -40.3° (c = 0.94 in ethanol)
Flash point:: 9℃
storage temp.: 2-8°C
solubility: soluble in Methanol
form: solid
pka: 10.13(at 25℃)
color: White to Almost white
Water Solubility: Soluble to 50 mM in water with gentle warming
Merck: 14,863
BCS Class: 1?
InChI: InChI=1/C17H21NO.ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15;/h3-11,17-18H,12-13H2,1-2H3;1H/t17-;/s3
InChIKey: LUCXVPAZUDVVBT-UNTBIKODSA-N
SMILES: O([C@H](CCNC)C1C=CC=CC=1)C1=CC=CC=C1C.Cl |&1:1,r|
CAS DataBase Reference: 82248-59-7(CAS DataBase Reference)

More

Less

Safety

Hazard Codes: F,T
Risk Statements: 11-23/24/25-39/23/24/25
Safety Statements: 22-24/25-45-36/37-16-7
RIDADR: UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany: 3
HS Code: 29221990

More

Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Danger

Hazard statements

H225Highly Flammable liquid and vapour

H370Causes damage to organs

Precautionary statements

P210Keep away from heat/sparks/open flames/hot surfaces. — No smoking.

P260Do not breathe dust/fume/gas/mist/vapours/spray.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

P311Call a POISON CENTER or doctor/physician.

More

Less

N-Bromosuccinimide Price

Sigma-Aldrich

Product number: A-095
Product name: Atomoxetine hydrochloride solution
Purity: 1.0?mg/mL in methanol (as free base), ampule of 1?mL, certified reference material, Cerilliant?
Packaging: 1mL
Price: $183
Updated: 2024/03/01

TCI Chemical

Product number: A2357
Product name: Atomoxetine Hydrochloride
Purity: >98.0%(HPLC)(T)
Packaging: 100mg
Price: $90
Updated: 2024/03/01

TCI Chemical

Product number: A2357
Product name: Atomoxetine Hydrochloride
Purity: >98.0%(HPLC)(T)
Packaging: 1g
Price: $511
Updated: 2024/03/01

Cayman Chemical

Product number: 22248
Product name: Atomoxetine (hydrochloride)
Packaging: 5mg
Price: $73
Updated: 2024/03/01

Cayman Chemical

Product number: 22248
Product name: Atomoxetine (hydrochloride)
Packaging: 50mg
Price: $431
Updated: 2024/03/01

More

Less

Atomoxetine hydrochloride Chemical Properties,Usage,Production

Description

Atomoxetine is the first non-stimulant marketed for the treatment of attention deficit hyperactivity disorder (ADHD). It is the R-stereoisomer of the racemate tomoxetine and is a selective and potent norepinephrine uptake inhibitor (K_i=0.7–1.9 nM) that is devoid of binding to monoamine receptor. It also has little effect on dopamine and serotonin reuptake or acetylcholine, H1 histamine, alpha1 or alpha1-adrenergic or dopamine receptors. It is prepared from racemic 1-phenylbut-3-en-1-ol via a selective enzymatic acylation leaving the desired S-stereoisomer as the alcohol. This alcohol is converted via a Mitsunobu reaction with ortho-cresol to the corresponding ether with isomeric R-configuration. Ozonolysis and reduction steps provided the terminal alcohol that is mesylated and displaced with methylamine. Its selectivity for norepinephrine relative to dopamine inhibition was demonstrated in vivo preclinically. In a two-lever (two condition) discriminative stimulus effect study in squirrel monkeys, tomoxetine and other norepinephrine uptake inhibitors substituted for cocaine under low-dose training conditions, whereas dopamine uptake inhibitors substituted for cocaine in both low and high-dose conditions. In clinical ADHD studies in adolescents, it was significantly different from placebo in 1.2 and 1.8 mpk/day dosing. In the clinical study in adults using the CAARS scale a 95 mg/day dose provided greater than 30% improvement in total scores. Atomoxetine is about 63% orally bioavailable, is highly protein bound (98%, primarily to albumin) and has a half-life of about 5.2 h. It is metabolized by CYP2D6 resulting in differential clearance for poor metabolizers (halflife of 19 h with a 10 times higher AUC) relative to extensive metabolizers. The total daily dose for children, adolescents and adults is a maximum of 100 mg/day. Common side effects in children and adults include nausea, decreased appetite, and dizziness. Adults may also have insomnia.

Description

Atomoxetine is a selective norepinephrine reuptake inhibitor with K_i values of 5, 77, and 1,451 nM for norepinephrine, serotonin, and dopamine transporters, respectively. It is selective over the choline, GABA, and adenosine transporters, and a number of neurotransmitter receptors, ion channels, second messengers, and brain/gut peptides. In the rat prefrontal cortex (PFC), it increases extracellular norepinephrine and dopamine by 3-fold and increases Fos expression. Atomoxetine (0.1, 0.5, and 1 mg/kg) reduces premature responding, a measure of impulsivity, by rats in the 5-choice serial reaction time test (5CSRTT) in a dose-dependent manner. It also has neuroprotective effects when administered prior to ischemic damage in a gerbil model of transient cerebral ischemia. Formulations containing atomoxetine have been used in the treatment of attention-deficit hyperactivity disorder (ADHD) in children, adolescents, and adults.

Chemical Properties

White Solid

Originator

Eli Lilly & Co (US)

Uses

(R)-Tomoxetine hydrochloride has been used as a noradrenaline reuptake inhibitor:

to study the role of L-threo-3,4-dihydroxyphenylserine (L-DOPS) in the pathogenesis of Alzheimer′s disease in mice
to study its effects on set shifting in rats
to study its effects on rat brain as a result of its long-term use

Uses

Atomoxetine hydrochloride, a Norepinephrine reuptake inhibitor, is used as a Psychotherapeutic and anti-depressant. These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications, including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. Atomoxetine hydrochloride may be used as a pharmaceutical reference standard for determining atomoxetine hydrochloride in pharmaceutical formulations by spectrophotometric method.

Definition

ChEBI: The hydrochloride salt of atomoxetine.

brand name

Strattera (Lilly).

General Description

Atomoxetine hydrochloride is a nonstimulant used in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults.

Biological Activity

Potent and selective noradrenalin re-uptake inhibitor (K i values are 5, 77 and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively). Displays minimal affinity for a range of other neurotransmitter receptors and transporters (K i > 1 μ M). Antidepressant.

Biochem/physiol Actions

Norepinephrine uptake blocker.

Synthesis

The 3-aryloxy substituent was introduced utilizing a chiral alcohol by either the Mitsunobu reaction or by nucleophilic aromatic displacement. Because of the expense and difficulty of the Mitsunobu reaction on large scale, the commercial process adopts the nucleophilic aromatic substitution method. 3- Chloropropiophenone (37) was asymmetrically reduced with borane and catalytic amount of (S)-oxazaborolidine (8) in THF at 0??C to give chiral alcohol 38 in 99% yield and 94% e.e. The chiral alcohol was further purified by recrystallization to greater than 99% e.e.. Subsequent treatment of chloride 38 with excess dimethylamine (40% in water) in ethanol gave dimethylamine alcohol 39 in 90% yield. Alcohol 39 was then subjected to nucleophilic aromatic displacement in the presence of NaH in DMSO with 1- fluoro-2-(t-butylimino)benzene (41), which was prepared in high yield from 2-fluorobenzaldehyde (40). The displacement product 42 was obtained in 98% yield, and the imine 42 was subsequently hydrolyzed with acetic acid in water at low temperature to give the corresponding aldehyde 43 in 96% yield. Sodium borohydride was employed to reduce aldehyde 43 to alcohol in cold methanol and the intermediate alcohol was converted to chloride 44 with thionyl chloride. Chloride 44 was then reduced with zinc metal under acidic conditions to give methyl adduct 45 in 95% yield and 94% e.e. Finally, phenyl chloroformate and triethylamine was used to transform dimethylamine 45 to monomethyl amine, which was subsequently treated with HCl in EtOAc under reflux to give atomoxetine hydrochloride (IV) in 98% yield and 99% e.e. from 45.

storage

Store at RT

Clinical claims and research

Atomoxetine hydrochloride was assessed in four randomized, double-blind, placebo-controlled studies involving 759 paediatric patients (ages 6 to 18 years old) who met the Diagnostic and Statistical Manual 4th edition (DSM-IV) criteria for ADHD. Signs and symptoms of ADHD were evaluated by a comparison of mean change from baseline to endpoint for atomoxetine hydrochloride-treated and placebo-treated patients using an intent-to-treat analysis of the primary outcome measure, the investigator-administered and -scored ADHD Rating Scale-IV-Parent Version (ADHDRS) total score. In all four trials, which lasted six to nine weeks, improvements in ADHD symptoms were significantly superior in patients receiving atomoxetine hydrochloride compared with those receiving placebo. Atomoxetine hydrochloride was also studied in two randomized, double-blind, placebo-controlled studies involving 536 adult patients who met DSM-IV criteria for ADHD. Signs and symptoms were evaluated using the investigator-administered Conners Adult ADHD Rating Scale Screening Version (CAARS). In both studies, which lasted ten weeks, ADHD symptoms were significantly improved in those patients receiving atomoxetine hydrochloride[1].

References

[1] Melissa Garland, Peter Kirkpatrick. “Atomoxetine hydrochloride.” Nature Reviews. Drug Discovery 3 5 (2004): 385–386.

Atomoxetine hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Atomoxetine hydrochloride Suppliers

Americas 1 Canada 6 China 362 Europe 3 Finland 1 France 4 Germany 5 India 65 Israel 2 Japan 1 South Korea 1 Switzerland 1 The Netherlands 2 United Arab Emirates 1 United Kingdom 16 United States 54 Global 525

Novachemistry

Tel: 44-20819178-90 02081917890
Fax: (0)2080432064
Email: info@novachemistry.com
Country: United Kingdom
ProdList: 4381
Advantage: 58

Carbosynth

Tel: --
Fax: --
Email: sales@carbosynth.com
Country: United Kingdom
ProdList: 6005
Advantage: 58

Biokemix

Tel: --
Fax: --
Email: info@biokemix.com
Country: United Kingdom
ProdList: 1066
Advantage: 58

Archimica UK

Tel: --
Fax: --
Country: United Kingdom
ProdList: 190
Advantage: 58

Chirotech Technology Limited

Tel: --
Fax: --
Country: United Kingdom
ProdList: 31
Advantage: 58

AA Zentivus Ltd.

Tel: --
Fax: --
Email: enquiries@aazentivus.com
Country: United Kingdom
ProdList: 89
Advantage: 58

Bio-Techne Ltd. (Tocris Bioscience)

Tel: --
Fax: --
Email: info.emea@bio-techne.com
Country: United Kingdom
ProdList: 120
Advantage: 58

Sequoia Research Products Ltd

Tel: --
Fax: --
Country: United Kingdom
ProdList: 466
Advantage: 58

CMS Chemicals Limited

Tel: --
Fax: --
Email: cms.marketing@cms-chemicals.com
Country: United Kingdom
ProdList: 3708
Advantage: 60

KEMPROTEC Limited

Tel: --
Fax: --
Email: enquiries@kemprotec.com
Country: United Kingdom
ProdList: 495
Advantage: 47

Tocris Bioscience

Tel: --
Fax: --
Email: customerservice@tocris.co.uk
Country: United Kingdom
ProdList: 5726
Advantage: 77

Apin Chemicals Limited (UK)

Tel: --
Fax: --
Email: info@apinchemicals.com
Country: United Kingdom
ProdList: 6184
Advantage: 60

Whyte Chemicals

Tel: --
Fax: --
Email: sales@whytechemicals.co.uk
Country: United Kingdom
ProdList: 3748
Advantage: 50

Eurolabs Limited

Tel: --
Fax: --
Country: United Kingdom
ProdList: 6309
Advantage: 46

Sequoia Research Products Ltd.

Tel: --
Fax: --
Email: sales@seqchem.com
Country: United Kingdom
ProdList: 3113
Advantage: 69

Apin Chemicals Ltd.

Tel: --
Fax: --
Email: info@apinchemicals.com
Country: United Kingdom
ProdList: 6807
Advantage: 42

More

Less

View Lastest Price from Atomoxetine hydrochloride manufacturers

Sinoway Industrial co., ltd.

Product: Atomoxetine Hydrochloride 82248-59-7
Price: US $0.00/Kg/Bag
Min. Order: 2Kg/Bag
Purity: 99% up, High Density
Supply Ability: 20 tons
Release date: 2021-07-21

S&Y Biochem Co.,Ltd

Product: Atomoxetine hydrochloride 82248-59-7
Price: US $1.00/kg
Min. Order: 1kg
Purity: 99
Supply Ability: 100
Release date: 2024-10-14

Baoji Guokang Bio-Technology Co., Ltd.

Product: Atomoxetine hydrochloride 82248-59-7
Price: US $1365.00/Kg/Bag
Min. Order: 1KG
Purity: 99
Supply Ability: 1T
Release date: 2021-06-04

82248-59-7, Atomoxetine hydrochlorideRelated Search:

Fluoxetine hydrochloride Moxifloxacin hydrochloride 3-Chloropropyltriethoxysilane 3-Mercaptopropyltriethoxysilane ISOPROPYLHYDRAZINE HYDROCHLORIDE Methylparaben Basic Violet 1 Kresoxim-methyl Topotecan hydrochloride Methyltrimethoxysilane Methyltriethoxysilane Methyl acrylate Methanol Cyclopropyl methyl ketone Acetonitrile Paraquat dichloride 3-Aminopropyltriethoxysilane Dimethyldimethoxysilane

ATOMOXETINE

ATOMOXETINE HCL

ATOMOXETINE HYDROCHLORIDE

METHYL-(3-PHENYL-3-O-TOLYLOXY-PROPYL)-AMINE HYDROCHLORIDE

(R)-N-METHYL-GAMMA-(2-METHYLPHENOXY)-BENZENEPROPANAMINE HYDROCHLORIDE

(r)-tomoxetine hydrochloride

TOMOXETINE HYDROCHLORIDE

Atomoxetine HCI

(R)-N-methyl-gamma-(2-methylphenoxy)-benzenepropanamine

(R)-N-Methyl-g-(2-methylphenoxy)benzenepropanaminehydrochloride

R-Tomexetine, Hydrochloride, (R)-N-Methyl--(2-methylphenoxy)benzenepropanamine, Hydrochloride

(r)-n-methyl-γ-(2-methyl-phenoxy)benzenepropanamine hydrochloride

ATOMOXETINEHYDROCHLORIDE(FORR&DONLY)

ATOMOXITINE

Atomexine Hydrochloride

(R)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropylamine Hydrochloride

Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine hydrochloride

Atomoxetine hydrochloride, 99%, a selective norepinephrine reuptake inhibitor

(R)-N-METHYL-3-PHENYL-3-(O-TOLYLOXY)PROPAN-1-AMINE HCL

Atomoxetine hydrochloride, (R)-N-Methyl-γ-(2-methylphenoxy)benzenepropanamine hydrochloride

Atomoxitine HCL

LY 139603

R-Tomexetine Hydrochloride

Strattera

(3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine hydrochloride

(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine hydrochloride

methyl-[(3R)-3-(2-methylphenoxy)-3-phenyl-propyl]amine hydrochloride

BenzenepropanaMine,N-Methyl-g-(2-Methylphenoxy)-,hydrochloride (

(R)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropylamine Hydrochloride (R)-Tomoxetine Hydrochloride

(R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-aMine hydrochloride

BenzenepropanaMine,N-Methyl-g-(2-Methylphenoxy)-,hydrochloride (1:1), (gR)-

(R)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propan-1-aMine hydrochloride, 95+%

LY 139603 HCl

Atomoxetine hydrochloride (R)-Tomoxetine hydrochloride

(R)-Atomoxetine hydrochloride

Atomoxetine for impurity A identification

Atomoxetine hydrochloride solution

Atomoxetine Hydrochloride (125 mg)

Atomoxetine Hydrochloride Impurity

Benzenepropanamine,N-methyl-g-(2-methylphenoxy)-,hydrochloride,(R)-

Atomoxetine Hydrochloride IMP

Atazanavir HCl

Atomoxetine hydrochloride CRS

Atomoxetine Hydrochloride &gt

(R)-Atomoxetine HCl

Atomoxetine hydrochloride USP/EP/BP

Tomoxetine hydrochloride impurity

Atomoxetine HCl (Tomoxetine

Atomoxetine HydrochlorideQ: What is Atomoxetine Hydrochloride Q: What is the CAS Number of Atomoxetine Hydrochloride Q: What is the storage condition of Atomoxetine Hydrochloride Q: What are the applications of Atomoxetine Hydrochloride

(R)-(-)-Atomoxetine-D5 HCl

Atomoxetine Hydrochloride (1044469)

(R)-N-methyl-N-(3-phenyl-3-(o-tolyloxy)propyl)formamide

Atomoxetine Impurity 7 HCl

Atomoxetine hydrochloride hcl

2H7]-Atomoxetine HCl (Racemic)

Atomoxetine hydrochloride in methanol

82248-59-7

C17H21NOClH